Knoll Pharmaceuticals Limited
About Knoll Pharmaceuticals Limited
Data last updated:
Knoll Pharmaceuticals Limited is a public limited company based in Badli, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 September 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U00304DL2005PLC140896. Its GSTIN is 07AABCJ6858M1ZZ (Delhi).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹13.6 Lakh. It was formerly known as J.B.B. Healthcare Limited. It is led by directors including Vikas Goel and Vishnu Bhagwan Goel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at M – 17 Pharma Tower First Floor Badli Industrial Area, Delhi, India – 110042.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.12 Cr, a growth of 124% compared to the previous year. For the same year it recorded a net profit of ₹53.68 Lakh (net margin 4.1%) and EBITDA of ₹77.63 Lakh (EBITDA margin 5.9%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years and 1% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
Court records list 47 cases involving the company, including 15 filed by the company and 32 filed against it; 8 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Knoll Pharmaceuticals Limited's registered office is in Badli, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressM – 17 Pharma Tower First Floor Badli Industrial Area, Delhi, India – 110042
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Knoll Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Knoll Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Knoll Pharmaceuticals Limited, buy the company report.
Financials of Knoll Pharmaceuticals Limited
FY 2025 filings availableKnoll Pharmaceuticals Limited reported revenue of ₹13.12 Cr (up 124% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 124% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA rose 255% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹77.63 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹53.68 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | ||||
| Net Profit Margin | 4.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Knoll Pharmaceuticals Limited, buy the company report.
Board of directors of Knoll Pharmaceuticals Limited
Knoll Pharmaceuticals has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikas Goel Also directs: Victoris Print Solutions LLP, Palohma Healthcare Private Limited, Bioford Remedies Private Limited and 3 more | Director | 19 Sep 2005 | 21 Years 1 Months | Current |
| Vishnu Bhagwan Goel | Director | 19 Sep 2005 | 21 Years 1 Months | Current |
| Sunil Goel | Director | 01 Nov 2011 | 14 Years 11 Months | Current |
| Nishant Gupta Also directs: Knoll Healthcare Private Limited | Director | 29 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Knoll Pharmaceuticals Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bio Warriors Pharmaceucticals Private Limited | ₹13.16 Cr (FY 2024) | 15.0% | Bangalore, Karnataka, India | |||
| Wynclark Pharmaceuticals Private Limited | ₹13.13 Cr (FY 2025) | -70.0% | Hyderabad, Telangana, India | |||
| Modi Remedies Private Limited | ₹13.12 Cr (FY 2025) | 35.0% | Cuttack, Odisha, India | |||
| Knoll Pharmaceuticals Limitedthis company | ₹13.12 Cr (FY 2025) | ₹53.68 Lakh | 4.1% | 124.0% | 2 | Badli, Delhi, India |
| M B and K Pharma Private Limited | ₹13.11 Cr (FY 2025) | 3.0% | Varanasi, Uttar Pradesh, India | |||
| Kaps Three Life Sciences Private Limited | ₹13.11 Cr (FY 2024) | 6.0% | Surendranagar, Gujarat, India | |||
| Merit Polychem Pvt. Ltd. | ₹13.11 Cr (FY 2025) | -7.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Knoll Pharmaceuticals Limited, buy the company report.
Auditor
Knoll Pharmaceuticals Limited is audited by DHIRAJ AGGARWAL & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DHIRAJ AGGARWAL & ASSOCIATES | FY 2024 | 036914N |
Shareholding
The shareholding of Knoll Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Knoll Pharmaceuticals Limited, buy the company report.
Legal cases
Knoll Pharmaceuticals Limited has 47 court cases on record: 15 filed by Knoll Pharmaceuticals, 32 filed against it. 8 cases are pending and 39 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 35 | 25 | 6 |
| District courts | 10 | 6 | 2 |
| Supreme Court | 2 | 1 | 0 |
Cases on record (5 of 47)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (LPETN) | Filed against the company by J.B. Chemicals and Pharmaceuticals Ltd. | Pending |
| Bombay High Court | Court case (CHOL) | Filed against the company by J.B. Chemicals and Pharmaceuticals Ltd. | Disposed |
| Bombay High Court | Court case (S) | Filed against the company by J.B. Chemicals and Pharmaceuticals Ltd. | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by J.B. Chemicals and Pharmaceuticals Ltd. | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMONS CASES SS) | Filed by the company against Finoglobal Exports Ltd. | Disposed |
To see the full case history of Knoll Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Knoll Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Knoll Pharmaceuticals Limited has a workforce of 2 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
GST
Knoll Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCJ6858M1ZZ | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Knoll Pharmaceuticals Limited, buy the company report.
Recent activity
Knoll Pharmaceuticals Limited has 8 board changes on record since 2005: 4 appointments and 4 cessations. The latest: Nishant Gupta ceased to be Additional Director on 29 Sep 2025.
Frequently asked questions
Knoll Pharmaceuticals is an active public limited company based in Badli, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 September 2005 (21+ years old) and is registered under CIN U00304DL2005PLC140896.
Knoll Pharmaceuticals has 4 current directors:
- Vikas Goel - Director
- Vishnu Bhagwan Goel - Director
- Sunil Goel - Director
- Nishant Gupta - Director
The latest financial statements of Knoll Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Knoll Pharmaceuticals is 07AABCJ6858M1ZZ, registered in Delhi.
The CIN (Corporate Identification Number) of Knoll Pharmaceuticals is U00304DL2005PLC140896. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Knoll Pharmaceuticals has 47 court cases on record: 15 filed by the company and 32 filed against it. 8 are pending. Most are in the high courts.
Knoll Pharmaceuticals was incorporated on 19 September 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Knoll Pharmaceuticals by revenue are Bio Warriors Pharmaceucticals Private Limited, Wynclark Pharmaceuticals Private Limited, Modi Remedies Private Limited, M B and K Pharma Private Limited, Kaps Three Life Sciences Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Nishant Gupta ceased to be Additional Director on 29 Sep 2025. Nishant Gupta was appointed as Director on 29 Mar 2025. Vishnu Bhagwan Goel ceased to be Director on 29 Mar 2025. Knoll Pharmaceuticals has 8 board changes on record in total.
The registered office of Knoll Pharmaceuticals is at M – 17 Pharma Tower First Floor Badli Industrial Area, Delhi, India – 110042.
Knoll Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
